EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

Clinical trials for EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER explained in plain language.

Never miss a new study

Get alerted when new EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER trials appear

Sign up with your email to follow new studies for EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Trained immune cells join fight against Post-Transplant cancer in kids

Disease control Completed

This study tested a two-part treatment for children and young adults who developed a specific type of cancer after an organ transplant. The cancer is linked to the Epstein-Barr virus. Researchers combined a standard antibody drug (rituximab) with specially trained immune cells de…

Matched conditions: EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

Phase: PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control

Last updated Apr 02, 2026 04:12 UTC

EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER

Get alerted when new EBV-RELATED POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER trials appear

Trained immune cells join fight against Post-Transplant cancer in kids